News

Novo Nordisk has previously reached a corporate decision to exit the oncology therapeutic area, resulting in the suspension of all ongoing oncology programs. Under the terms of the

This agreement resolves the parties’ dispute that was pending in the District Court of Texas. Acacia Research’s subsidiaries develop, acquire, and license patented technologies. They control over 100

Under the terms of the agreement, Millipore will pay $22.6 million, subject to closing adjustments, to acquire Guava. The transaction is expected to be slightly accretive to Millipore’s

As a result of their affiliation, American patients will receive access to specialized spine centers committed to transparency, quality, protocol-driven care and continuous quality improvement for the treatment

Elesclomol is being developed under a global collaboration agreement between Synta Pharmaceuticals and GlaxoSmithKline and is not approved for marketing by the FDA or any other similar regulatory

The company has been streamlining and refining its operations over the past 18 months. In the final stage of the process carried out recently, the number of staff

Protect is powered to detect a clinically significant difference in rates of stent thrombosis between the two devices. Protect’s primary endpoint is overall stent thrombosis at three years;

The studies showed that ADX48621, a metabotropic glutamate receptor 5 negative allosteric modulator in development for Parkinson’s disease levodopa induced dyskinesia (PD-LID), is safe and well-tolerated in healthy

Under the terms of the agreement, Church & Dwight acquired exclusive world-wide rights to use certain QuantRx technology related to a jointly developed at-home diagnostic test for the